Skip to main content

Table 3 Count of activities mentioned in pharmacovigilance excerpts from Africa, stratified by type (N = 188)

From: Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries

Pharmacovigilance area of interest

Activity type

Adverse events

Counterfeit drugs

Drug quality assurance

PV NOS

NA

Total

 Behaviour change communication

 

3 (75.0)

1 (25.0)

  

4 (2.1)

 Improve regulatory system

 

5 (19.2)

12 (46.2)

9 (34.6)

 

26 (13.8)

 Improving supply chain

  

5 (45.4)

6 (54.5)

 

11 (5.9)

 Laboratory supplies and training

 

4 (18.2)

17 (77.3)

1 (4.5)

 

22 (11.7)

 Operations research

2 (100)

    

2 (1.1)

 Pharmacovigilance NOS

2 (8.7)

5 (21.7)

15 (65.2)

1 (4.3)

 

23 (12.2)

 Surveillance

2 (9.5)

5 (23.8)

13 (61.9)

1 (4.8)

 

21 (11.2)

 Training/capacity building

  

5 (55.6)

4 (44.4)

 

9 (4.8)

 Surveillance-not funded

1 (100)

    

1 (0.5)

 Pharmacovigilance NOS-unfunded

  

6 (100)

  

6 (3.2)

 Context onlya

    

35 (100)

35 (18.6)

 Historical activityb

 

6 (13.3)

26 (57.8)

12 (26.7)

1 (3.8)

45 (23.9)

 Total

7 (3.7)

22 (11.7)

94 (50.0)

35 (18.6)

36 (19.1)

188 (100.0)

  1. aExcerpts that described pharmacovigilance activities occurring within the country but that were not supported or funded by the current or past grants
  2. bExcerpts that described pharmacovigilance activities that were previously funded by the grant making organization but were not being supported in the current grant